Építés alatt – nem éles oldal
Belépés

Petefészekrák trials, also abroad

803 open Petefészekrák trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Egyesült Államok351
Olaszország101
Franciaország99
Spanyolország90
Dél-Korea65
All other countries

The same trial often runs in several countries

Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer has 32 sites in Kína and runs in 29 countries. If a site near you is full, another one may still take people.

See Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer in all 29 countries
Építés alatt, nem éles – Petefészekrák: vizsgálatok itt: Kína – Frontlight Research